TokenPost·
EU Approves Incyte's Povofortay for Adults With Limited Anti-TNF Options

The authorization covers active moderate to severe hidradenitis suppurativa. U.S. regulators are reviewing an application for the same drug.
Every crypto headline. One feed. Updated every minute.

The authorization covers active moderate to severe hidradenitis suppurativa. U.S. regulators are reviewing an application for the same drug.